Abstract
Huntington's disease (HD) is a fatal neurodegenerative genetic disease that causes devastating changes to cognition, behaviour, and motor function. Currently, it is incurable, and medications manage symptoms with limited efficacy.
Recent focus has turned to the potential of regenerative therapies like gene silencing and stem cells to slow disease progression. These invasive therapies are ethically controversial, and knowledge of patient's attitudes towards them is limited. This study aimed to determine what New Zealanders affected by HD know about regenerative therapies, what they believe motivates researchers, and what should motivate them.